| Autor: |
Otsubo K; Department of Pediatrics, Faculty of Medicine, Kagoshima University, Kagoshima, Japan., Mizota M; Department of Pediatrics, Faculty of Medicine, Kagoshima University, Kagoshima, Japan., Hizukuri K; Department of Pediatrics, Faculty of Medicine, Kagoshima University, Kagoshima, Japan., Tamada I; Department of Pediatrics, Faculty of Medicine, Kagoshima University, Kagoshima, Japan., Arima S; Department of Pediatrics, Faculty of Medicine, Kagoshima University, Kagoshima, Japan., Ono S; Ibusuki Public Health Center, Kagoshima, Japan., Kawano Y; Department of Pediatrics, Faculty of Medicine, Kagoshima University, Kagoshima, Japan. |
| Abstrakt: |
We encountered a case with hyperthyroidism at the age of 14 who had been diagnosed with congenital hypothyroidism (CH) and had received thyroid hormone replacement therapy. At the age of 16 d, the patient was referred to our hospital because of positive results at neonatal screening for CH. Serum level of TSH was 91.0 μU/ml and serum level of T4 was 6.9 μg/dl. The patient was diagnosed as having hypothyroidism, and hormone replacement therapy was started. Thereafter the dosage of thyroid hormone was adjusted and increased gradually as he grew to a maximum dose of 110 μg/day at the age of 11. Until the age of 13, the patient's serum levels of TSH were within the normal range; then, at the age of 13 yr and 4 mo, his serum level of TSH dropped to a level below the detectable range. The dosage of administered thyroid hormone was tapered off and eventually eliminated at the age of 14. A thyroid scan and a radioactive iodine uptake test demonstrated a diffuse goiter with homogeneous uptake of radioactive iodine; the uptake rate was 60% at 24 h, and the serum level of TSH receptor antibody (TRAb) was 62.5% at that time. Administration of an antithyroid drug was started after confirmation that our patient had developed hyperthyroidism. There have been no case reports similar to our case. |
